Sign InBreakout Stocks of Week 10 @ OMX
NASDAQ was down last week (week 9) by -0.95% ending at 22,668.21 points after falling -217.86 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Orexo AB (publ) OMX:ORX. This stock has had a buy signal since Feb 27, 2026 when the price was kr28.20 , but have so far fallen 0% to kr28.20. Some other companies are on our watchlist to, among these are Knowit AB (publ) OMX:KNOW Skandinaviska Enskilda Banken AB (publ.) OMX:SEB-A XANO Industri AB (publ) OMX:XANO-B and Xvivo Perfusion AB (publ) OMX:XVIVO which all got a breakout pattern emerging.
| Date | Company | Price | Week 10 |
|---|---|---|---|
| Orexo Ab (publ) | kr28.20 | kr25.40 | -9.93% |
| Knowit Ab (publ) | kr112.60 | kr111.40 | -1.07% |
| Skandinaviska Enskilda Banken Ab (publ.) | kr192.80 | kr183.80 | -4.67% |
| Xano Industri Ab (publ) | kr66.00 | kr60.50 | -8.33% |
| Xvivo Perfusion Ab (publ) | kr187.50 | kr182.10 | -2.88% |
The Orexo AB (publ) stock price gained 6.42% on the last trading day (Friday, 27th Feb 2026), rising from kr26.50 to kr28.20. During the last trading day the stock fluctuated 9.07% from a day low at kr25.90 to a day high of kr28.25. The price has risen in 6 of the last 10 days and is up by 4.06% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 41 thousand more shares were traded than the day before. In total, 76 thousand shares were bought and sold for approximately kr2.13 million.
Orexo AB (publ) holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About Orexo AB (publ):
Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Its products include Zubsolv tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of short-term insomnia. The company's development products comprise OX124, a medication for naloxone rescue; OX125, a medication for nalmefene rescue; OX640, a medication for allergic reactions; and OX338 sublingual tablet formulation of ketorolac for treatment of moderate to severe pain. It is also developing OX-MPI program for the treatment of microvascular diseases in chronic inflammatory conditions. The company's digital therapies comprise deprexis therapy for the treatment of mild to severe depression; vorvida for alcohol use disorder; and modia for opioid use disorder. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden.
The Knowit AB (publ) stock price gained 0.357% on the last trading day (Friday, 27th Feb 2026), rising from kr112.20 to kr112.60. During the last trading day the stock fluctuated 1.25% from a day low at kr111.60 to a day high of kr113.00. The price has fallen in 8 of the last 10 days and is down by -8.31% for this period. Volume fell on the last day by -30 thousand shares and in total, 24 thousand shares were bought and sold for approximately kr2.75 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Knowit AB (publ) holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About Knowit AB (publ):
Knowit AB (publ), a consultancy company, provides digital solutions in the Nordic region. The company operates through four segments: Solutions, Experience, Connectivity, and Insight. It offers services in the areas of product and service development, security, and cloud services; Website and mobile solutions, analysis and insight, E-commerce, digital marketing and CRM, and design and branding; and digital transformation and innovation, system development and management, data driven operations and analytics, and system solution and platform. The company also provides services in the areas of working capital and supply chain management; finance transformation; digital human resource and payroll; digitalization and IT operations; sourcing and procurement; growth and digital strategies; profitability programs and management; and commercial excellence and pricing strategy. In addition, it offers digital and agile transformation; automation and data analytics; project management; realization and implementation; quality management; organizational development and design; and change leadership and management solutions. It serves banking and finance, insurance, energy, manufacturing, life science and medical, manufacturing, media and education, public, retail and services, and telecom sectors. The company was formerly known as Know IT AB (publ.) and changed its name to Knowit AB (publ) in April 2012. Knowit AB (publ) was incorporated in 1990 and is headquartered in Stockholm, Sweden.
The Skandinaviska Enskilda Banken AB (publ.) stock price fell by -1.56% on the last day (Friday, 27th Feb 2026) from kr195.85 to kr192.80. During the last trading day the stock fluctuated 1.82% from a day low at kr192.35 to a day high of kr195.85. The price has risen in 6 of the last 10 days and is up by 2.12% over the past 2 weeks. Volume has increased on the last day by 409 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 million shares were bought and sold for approximately kr651.58 million.
The Skandinaviska Enskilda Banken AB (publ.) stock holds several negative signals and despite the positive trend, we believe Skandinaviska Enskilda Banken AB (publ.) will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
About Skandinaviska Enskilda Banken AB (publ.):
Seaboard Corporation operates as an agribusiness and transportation company worldwide. It operates through six segments: Pork, Commodity Trading and Milling (CT&M), Marine, Sugar and Alcohol, Power, and Turkey. The Pork segment produces and sells fresh and frozen pork products to further processors, foodservice operators, grocery stores, and distributors; hogs; and biodiesel. The CT&M segment sources, transports, and markets wheat, corn, soybeans, soybean meal, and other commodities; and produces wheat flour, maize meal, manufactured feed, and oilseed crush commodities. The Marine segment provides cargo shipping services in the United States, as well as in 26 countries in the Caribbean, and Central and South America; dry, refrigerated, and specialized containers, as well as other related equipment; and operates a terminal and an off-port warehouse for cargo consolidation and temporary storage. As of December 31, 2021, this segment operated through a fleet of 20 chartered and 4 owned vessels. The Sugar and Alcohol segment produces and sells sugar and alcohol; and generates and sells energy through its 51-megawatt cogeneration power plant that is fueled by sugarcane by-products, natural gas, and other biomass. The Power segment operates as an independent power producer that generates electricity for the power grid in the Dominican Republic. The Turkey segment produces and processes organic turkey products to retail stores, foodservice outlets, and industrial entities, as well as exports products to Mexico and internationally. The company also processes and sells jalapeño peppers. Seaboard Corporation was founded in 1918 and is headquartered in Merriam, Kansas.
The XANO Industri AB (publ) stock price fell by -0.752% on the last day (Friday, 27th Feb 2026) from kr66.50 to kr66.00. During the last trading day the stock fluctuated 5.89% from a day low at kr62.80 to a day high of kr66.50. The price has been going up and down for this period, and there has been a -2.22% loss for the last 2 weeks. Volume has increased on the last day by 36 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 54 thousand shares were bought and sold for approximately kr3.54 million.
XANO Industri AB (publ) holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
About XANO Industri AB (publ):
Addtech AB (publ.) operates as a technology trading company in Sweden, Denmark, Finland, Norway, rest of Europe, and internationally. The company operates through Automation, Electrification, Energy, Industrial Solutions, and Process Technology segments. It markets and sells intelligent solutions, subsystems, and components to industrial automation and infrastructure sector, including solutions for robotics, control systems, sensors, and industrial and communication networks. The company also offers battery systems; connectivity solutions; and intelligent power products, electronics, motors, and powertrain solutions. In addition, it produces and sells products for electricity transmission and electrical installation, as well as safety products for traffic and the home environment; and electricity distribution and communication network products to electricity network operators, contractors, wholesalers, railway companies, industrial customers, and hospitals. Further, the company produces and sells solutions and systems primarily for the forest, special vehicles, mechanical, and waste/recycling industries, as well as provides hydraulic solutions. Additionally, it provides process components, equipment, and systems for creating and processing flows; provides emission control products; and markets and sells instruments and valves for regulating and monitoring pressure, levels, flows, and energy. The company was founded in 1906 and is based in Stockholm, Sweden.
The Xvivo Perfusion AB (publ) stock price gained 0.81% on the last trading day (Friday, 27th Feb 2026), rising from kr186.00 to kr187.50. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 3.59% from a day low at kr181.00 to a day high of kr187.50. The price has risen in 6 of the last 10 days and is up by 1.3% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 21 thousand more shares were traded than the day before. In total, 88 thousand shares were bought and sold for approximately kr16.53 million.
Xvivo Perfusion AB (publ) holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
About Xvivo Perfusion AB (publ):
Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
GOLDEN STAR
| Ticker | Change | Signal Date |
|---|---|---|
TPR
$140.47
|
0.306% | Jun 04 |
|
N
NVRI
$19.53
|
1.79% | May 20 |
RUN
$12.83
|
4.91% | May 06 |
GLBE
$31.61
|
1.71% | May 05 |
SAP
$172.39
|
5.53% | May 05 |
